Aspen has not held its bullish break.
Thanks so much for this
Jump to content
Posted 06 August 2020 - 01:56 PM
Posted 25 June 2020 - 05:51 PM
“If you don’t have these medicines, you shouldn’t have the doors of your hospital open,” said Lucio.
With U.S. hospitals ordering dexamethasone at higher levels than normal, suppliers are distributing both an oral tablet and injectable form of the drug. Observers are confident the eight companies that make the drug can ramp up production enough to handle the demand.
Posted 18 June 2020 - 09:08 PM
Aspen is not the only manufacturer and the drug is cheap
Posted 18 June 2020 - 12:47 PM
Posted 18 June 2020 - 11:51 AM
Saad added that Aspen is “well-positioned to go into quick production” of the drug within its South African, Australian and European operations.
Enquiries from all quarters
Asked if the group has already seen a spike in demand, he said Aspen has seen enquiries for the drug “from everywhere”, including the South African government and the WHO.
“Our government has contacted us a couple of times already, wanting to understand the capacity and capabilities we have,” he said. “And, interestingly not just enquiring for South Africa, but for all of Africa, which I was particularly pleased to see … sort of working continentally.”
Posted 18 June 2020 - 11:48 AM
Posted 17 June 2020 - 06:44 PM
Posted 17 June 2020 - 11:52 AM
Posted 17 June 2020 - 11:30 AM
Yes sir.. Dexamethasone. For icu patients ventilated as one of the treatment protocols. Been used in public hospitals with chloroquine since march
Sent from my SM-G950F using Sharenet Sharechat mobile app
yes, but now there's a stydy proving it saves lives. only drug so far to do that. Also Dr Mkhize and Dept of health came out with a statement late last night, saying they're adopting its use as policy.
Posted 17 June 2020 - 10:54 AM
Posted 17 June 2020 - 10:45 AM
Use of Dexamethasone in the clinical management of patients with COVID-19 requiring respiratory intervention ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 and its subsidiaries (collectively “Aspen” or “the Group”) USE OF DEXAMETHASONE IN THE TREATMENT OF PATIENTS WITH COVID-19 REQUIRING RESPIRATORY INTERVENTION To ensure the equal distribution of information which may possibly be price sensitive, Aspen has noted the preliminary results of a drug trial using dexamethasone in the treatment of patients with COVID-19 requiring respiratory intervention and the related media coverage. It is confirmed that Aspen owns rights to this product and distributes both injectables and/or tablets containing dexamethasone in a number of countries. Aspen markets an injectable dexamethasone in South Africa, which is manufactured locally by a third party.
Posted 15 June 2020 - 01:35 PM
Posted 14 April 2020 - 07:05 PM
Posted 30 March 2020 - 05:20 PM
Posted 25 February 2020 - 10:07 AM
Posted 22 February 2020 - 11:38 AM